Sera Prognostics, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SERA research report →
Companyseraprognostics.com
Sera Prognostics, Inc. , a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies.
- CEO
- Zhenya Lindgardt
- IPO
- 2021
- Employees
- 63
- HQ
- Salt Lake City, UT, US
Price Chart
Valuation
- Market Cap
- $67.22M
- P/E
- -2.75
- P/S
- 1179.23
- P/B
- 1.31
- EV/EBITDA
- -2.02
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -191.23%
- Op Margin
- -64235.09%
- Net Margin
- -56385.96%
- ROE
- -41.02%
- ROIC
- -52.21%
Growth & Income
- Revenue
- $81.00K · 5.19%
- Net Income
- $-31,928,000 · 2.95%
- EPS
- $-0.67 · 32.32%
- Op Income
- $-36,504,000
- FCF YoY
- -72.33%
Performance & Tape
- 52W High
- $4.09
- 52W Low
- $1.37
- 50D MA
- $1.98
- 200D MA
- $2.74
- Beta
- 0.93
- Avg Volume
- 59.75K
Get TickerSpark's AI analysis on SERA
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 12, 26 | Kearney Paul | other | 0 |
| Mar 12, 26 | Harrison Robert Gardner | other | 0 |
| Mar 12, 26 | Boniface John J. | other | 0 |
| Mar 12, 26 | Lindgardt Zhenya | other | 154,440 |
| Mar 12, 26 | Lindgardt Zhenya | other | 239,442 |
| Mar 12, 26 | Jackson Benjamin | other | 44,215 |
| Mar 12, 26 | Jackson Benjamin | other | 68,550 |
| Mar 12, 26 | Inglis Tiffany Eul Davis | other | 17,437 |
| Mar 12, 26 | Inglis Tiffany Eul Davis | other | 27,034 |
| Mar 12, 26 | Anderson Dyaarl Lee Jr. | other | 12,455 |
Our SERA Coverage
We haven't published any research on SERA yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SERA Report →